全文获取类型
收费全文 | 31130篇 |
免费 | 1921篇 |
国内免费 | 744篇 |
专业分类
耳鼻咽喉 | 98篇 |
儿科学 | 378篇 |
妇产科学 | 97篇 |
基础医学 | 2253篇 |
口腔科学 | 298篇 |
临床医学 | 4428篇 |
内科学 | 7580篇 |
皮肤病学 | 62篇 |
神经病学 | 1012篇 |
特种医学 | 2044篇 |
外国民族医学 | 2篇 |
外科学 | 1803篇 |
综合类 | 4757篇 |
现状与发展 | 1篇 |
预防医学 | 2950篇 |
眼科学 | 140篇 |
药学 | 4153篇 |
20篇 | |
中国医学 | 1397篇 |
肿瘤学 | 322篇 |
出版年
2024年 | 41篇 |
2023年 | 318篇 |
2022年 | 847篇 |
2021年 | 1099篇 |
2020年 | 1020篇 |
2019年 | 801篇 |
2018年 | 824篇 |
2017年 | 860篇 |
2016年 | 887篇 |
2015年 | 1014篇 |
2014年 | 2032篇 |
2013年 | 2076篇 |
2012年 | 1865篇 |
2011年 | 2054篇 |
2010年 | 1737篇 |
2009年 | 1629篇 |
2008年 | 1689篇 |
2007年 | 1740篇 |
2006年 | 1637篇 |
2005年 | 1317篇 |
2004年 | 1026篇 |
2003年 | 953篇 |
2002年 | 767篇 |
2001年 | 688篇 |
2000年 | 651篇 |
1999年 | 542篇 |
1998年 | 424篇 |
1997年 | 378篇 |
1996年 | 275篇 |
1995年 | 322篇 |
1994年 | 255篇 |
1993年 | 181篇 |
1992年 | 197篇 |
1991年 | 180篇 |
1990年 | 152篇 |
1989年 | 132篇 |
1988年 | 139篇 |
1987年 | 134篇 |
1986年 | 100篇 |
1985年 | 136篇 |
1984年 | 112篇 |
1983年 | 72篇 |
1982年 | 91篇 |
1981年 | 53篇 |
1980年 | 48篇 |
1979年 | 66篇 |
1978年 | 58篇 |
1977年 | 35篇 |
1976年 | 45篇 |
1973年 | 26篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
促红细胞生成素心肌保护作用的研究进展 总被引:4,自引:0,他引:4
促红细胞生成素(erythropoietin,EPO)是一种造血细胞生长因子,主要用于治疗多种原因所致的贫血。近年来其非造血生物作用逐渐引起关注,EPO具有组织保护作用,这一作用涉及多种不同组织和细胞,心肌保护一直是心血管病研究领域重要、关键的课题。EPO对心肌保护的作用近两年已渐有报道,这无疑为临床心肌保护的研究提供了新的思路和方向。现就EPO心肌保护作用的相关研究成果、发现以及有待解决的问题作一综述。 相似文献
82.
老年人急性心肌梗塞的临床特点 总被引:2,自引:0,他引:2
王莹 《心血管康复医学杂志》2006,15(2):152-154
目的:研究60岁以上老年人急性心肌梗塞的临床特点。方法:对86例老年人急性心肌梗塞资料进行临床分析,并与同期255例小于60岁的急性心肌梗塞病人进行对比。结果:老年急性心肌梗塞患者女性的比例较60岁以下者明显增多(P<0.01),老年无痛性心肌梗塞比例(30.5%)明显增多(P<0.05),并发症心力衰竭(P<0.01)、心律失常(P< 0.05),死亡率(P<0.01)也明显增多。结论:老年人无痛性急性心肌梗塞多见,并发症发生率、死亡率高,应予重视。 相似文献
83.
84.
骨髓细胞移植上调血管内皮生长因子及其受体的表达并改善缺血心脏功能 总被引:14,自引:1,他引:13
目的:通过骨髓细胞移植对心肌梗死大鼠模型血管内皮生长因子及其受体表达的影响,探讨骨髓细胞移植改善缺血心脏功能的可能机制。方法:利用左前降支冠状动脉结扎术制备大鼠心肌梗死模型,然后行异体骨髓细胞移植;分别于术后1d,3d,7d,14d和28d取材;利用免疫荧光和RT—PCR技术分析细胞移植对血管内皮生长因子(VEGF)及其受体(Flk一1)表达的影响和移植细胞的分化情况;通过免疫组化计算血管数量;应用血流动力学检测大鼠心脏功能在术后各时间点的变化。结果:VEGF和Flk-1在移植组动物的心肌梗死区残存细胞、梗死周边区细胞以及部分移植细胞内表达。移植组VEGF和Flk-1的mRNA表达明显高于对照组。分别于术后3d和14d达到高峰,以后逐渐减弱。术后7d,14d和28d移植组血管数量较同期对照组明显增加,移植组心脏功能较对照组明显改善。术后14d可在部分移植细胞中检测到心肌细胞或血管内皮细胞特异性蛋白的表达。结论:骨髓细胞移植通过上调移植细胞及受者内源性VEGF和Flk—1的表达,促进血管新生,进而改善缺血心脏功能。 相似文献
85.
Michael C. Kontos Kristin L. Schmidt Michael McCue Louis F. Rossiter Michael Jurgensen Christopher S. Nicholson Robert L. Jesse Joseph P. Ornato James L. Tatum 《Journal of nuclear cardiology》2003,10(3):284-290
BACKGROUND: Our objective was to determine the cost-effectiveness of a comprehensive, risk-based triage system, composed of multiple critical pathways, with the use of early myocardial perfusion imaging (MPI) in low-risk patients. We found previously that a chest pain evaluation system that uses MPI in low-risk patients was safe and effective, but the cost-effectiveness of this approach was not studied. METHODS AND RESULTS: We compared two groups. The Acute Cardiac Team (ACT) group (n = 874) was assigned prospectively to 1 of 4 risk levels by emergency department (ED) physicians. Level 1, 2, and 3 patients were admitted; level 4 patients were evaluated in the ED. Level 3 and 4 patients underwent ED MPI. The control group (n = 713) represented consecutive patients evaluated in the prior year according to standard care and assigned retrospectively to an ACT level based on the presenting electrocardiographic and clinical data. Record and hospital administrative data were assessed for clinical variables, outcomes, lengths of stay, and all expenses incurred within 30 days of the index visit. The baseline characteristics of the two groups were similar, including age, sex, myocardial infarction prevalence, and 30-day revascularization rates within each level or between the two groups. Mean costs per encounter were reduced for the ACT patients for each level, which was significant when all patients were compared ($5,030 +/- $7,081 vs $6,044 +/- $10,432, P =.02). Use of MPI in the low-risk patients was associated with reduced costs (level 3, $4,958 +/- $4,948 vs $5,051 +/- $7,036; level 4, $1,529 +/- $2,664 vs $1,794 +/- $6,854) and was associated with a significantly lower angiography rate and shorter length of stay. CONCLUSIONS: Implementation of a comprehensive strategy for chest pain evaluation and triage reduced overall costs for patients with chest pain on presentation. Acute MPI in the ED setting did not increase net cost. 相似文献
86.
Use of the optimum finishing technique for an amalgam restoration may enhance the marginal integrity of the restoration and discourage its unnecessary early replacement. Two hundred and twenty-eight high copper amalgam restorations in 56 patients were evaluated, using clinical assessment criteria, up to three years after placement. Each patient had received at least one carved-only amalgam, at least one immediately finished restoration, and at least one amalgam that was polished at a subsequent appointment. Regardless of the finishing technique, the restorations exhibited similar marginal integrity up to three years after placement. Polished restorations were found to have substantially superior surface texture and less likelihood of surface discoloration. No evidence was found to support the use of immediate finishing techniques. The clinical significance of these findings, with respect to the need to polish amalgam restorations, is discussed. 相似文献
87.
Gérald Vanzetto Marc Janier Daniel Fagret Luc Cinotti Xavier André-Fouet Michel Comet Jacques Machecourt 《European journal of nuclear medicine and molecular imaging》1997,24(2):170-178
The best test presently available to ascertain residual viability within an infarct-related area involves the use of fluorine-18
fluorodeoxyglucose (FDG) to detect the persistence of some cellular metabolism. Rest reinjection of thallium-201 is a less
accurate alternative but is easy to perform. Iodinated fatty acids, which are used with standard gamma cameras, are proposed
as markers of cellular metabolism. This study was performed to assess the value of 16-iodo-3-methyl-hexadecanoic acid (MIHA)
as a marker of the residual cellular metabolism by comparison with FDG in patients with a recent myocardial infarction, and
to evaluate its contribution compared with the201Tl stress-redistribution-reinjection technique. Stress-redistribution-reinjection201T1 imaging, rest MIHA imaging and glucoseloaded FDG imaging were performed in 22 patients with recent myocardial infarction.
Out of the 628 myocardial segments obtained from the left ventricular analysis, 400 were hypoperfused (relative uptake <0.75
of maximum uptake on stress201T1 imaging), 177 of which were severely hypoperfused (relative uptake <0.50). Receiver operating characteristic (ROC) curves
for predicting metabolic myocardial viability with FDG were derived from the results in respect of (a)201T1 activity during exercise, redistribution and reinjection and (b) MIHA up-take, using the two FDG thresholds most commonly
considered to define metabolic viability (0.50 and 0.60). Analysis of the 400 hypoperfused segments demonstrated that201T1 reinjection was the most accurate test in predicting the presence of myocardial viability (area under the ROI curves=0.85
and 0.86 at the 0.50 and 0.60 FDG thresholds, respectively;P<0.05 vs other tests). The global predictive values of MIHA and201T1 reinjection were, respectively, 0.87 and 0.89 at the 0.50 FDG threshold (NS), and 0.82 and 0.87 at the 0.60 FDG threshold
(NS). When only the 177 severely hypoperfused segments were considered,201T1 reinjection remained the most accurate test (accuracy 0.84 at the 0.50 FDG threshold and 0.82 at the 0.60 FDG threshold),
while the accuracy of MIHA decreased significantly (0.78 at the 0.50 FDG threshold and 0.73 at the 0.60 FDG threshold,P<0.05 vs201T1 reinjection). In all circumstances, MIHA was less specific than201T1 reinjection for the detection of metabolic viability. In conclusion, in patients with recent myocardial infarction, MIHA
accurately detects the persistence of metabolic viability, but is not superior to201T1. 相似文献
88.
R. Raininko I. Elovaara E. Poutiainen A. Virta L. Valanne M. Haltia J. Lhdevirta 《European journal of neurology》1997,4(2):143-151
The course of the organic brain disease caused by human immunodeficency virus (HIV-1) was evaluated in a follow-up study. The primary material included 200 consecutive HIV-1 infected persons. Sixty-one subjects, in whom other brain-affecting factors were excluded, consented to the follow-up. They underwent 278 radiologic examinations: computed tomography, magnetic resonance imaging, or a combination of both (mean 4.6 examinations/subject). Clinical neurologic status and, in 40 subjects, cognitive performance were repeatedly evaluated. Sixteen subjects were followed up until death and 11 of them were autopsied. Median follow-up time was 27 mo (range 2.5–66 mo). The most common radiologic finding was atrophy, found in 19 subjects at study entry and developing in 10 subjects during the study. Twenty-four subjects (39%) showed the development and/or progression of atrophy. Atrophic changes progressed most rapidly in acquired immunodeficiency syndrome (AIDS), but mild developing/progressive atrophy was found even in 33% of asymptomatic or neurologically intact subjects. Cognitive and radiologic worsening were simultaneous in 6/7 subjects with declining neuropsychologic test performance. Signal intensity changes including HIV-1 leukoencephalopathy appeared in AIDS patients with clear cognitive decline. 相似文献
89.
Myocardial metabolic imaging by means of fluorine-18 deoxyglucose/technetium-99m sestamibi dual-isotope single-photon emission tomography 总被引:2,自引:1,他引:1
Hans-Peter Stoll Nicola Hellwig Christof Alexander Cem Özbek Hermann Schieffer Erich Oberhausen 《European journal of nuclear medicine and molecular imaging》1994,21(10):1085-1093
The detection of preserved glucose uptake in hypoperfused dysfunctional myocardium by fluorine-18 deoxyglucose (FDG) positron emission tomography (PET) represents the method of choice in myocardial viability diagnostics. As the technique is not available for the majority of patients due to cost and the limited capacity of the PET centres, it was the aim of the present work to develop and test FDG single-photon emission tomography (SPET) with the means of conventional nuclear medicine. The perfusion marker sestamibi (MIBI) was used together with the metabolic tracer FDG in dual-isotope acquisition. A conventional SPET camera was equipped with a 511-keV collimator and designed to operate with simultaneous four-channel acquisition. In this way, the scatter of 18F into the technetium-99m energy window could be taken into account by a novel method of scatter correction. Thirty patients with regional wall motion abnormalities at rest were investigated. The results of visual wall motion analysis by contrast cine-ventriculography in nine segments/heart were compared with the results of quantitative scintigraphy. The scintigraphic patterns of MIBI and FDG tracer accumulation were defined as normal, matched defects and perfusion-metabolism mismatches. Spatial resolution of the system was satisfactory, with a full width at half maximum (FWHM) of 15.2 mm for 18F and 14.0 mm for 99mTe, as measured by planar imaging in air at 5 cm distance from the collimator. Image quality allowed interpretation in all 30 patients. 88% of segments without relevant wall motion abnormalities presented normal scintigraphic results. Seventy-five akinetic segments showed mismatches in 27%, matched defects in 44% and normal perfusion in 29%. We conclude that FDG-MIBI dual-isotope SPET is technically feasible with the means of conventional nuclear medicine. Thus, the method is potentially available for widespread application in patient care and may represent an alternative to the 201T1 reinjection technique. 相似文献
90.
阿魏酸在血瘀证兔体内的药代动力学 总被引:2,自引:0,他引:2
为验证及研究症治药动学假说(syndromeandTreatmentPharmacokinetics,S&TPK)的客观性和基本规律,本文以RP-HPLC法同时测定了活血祛瘀药物阿魏酸在正常及高分子右旋糖酐所制血瘀症(微循环障碍)兔体内经时浓度,以MCPKP药动学程序在COMPAQ80386机上自动拟合了药动学参数。统计结果表明,与正常组相比,阿魏酸在血瘀症兔体内的分布容积(V_1和V_B)及消除速率(CLB)显著减小(P<0.05),半衰期(t_(1/2β)及相同时间段曲线下面积(AUQ)非常显著增加(P<0.01)。结论:实验结果基本符合S&TPK的观点:即同一药物在不同证兔体内的药代动力学参数经统计学处理有显著差异。 相似文献